Menu
Washingtoner
  • Home
  • Business
  • Aerospace
  • Transportation
  • Boeing
  • Kelly Ortberg
  • Manufacturing
  • Construction
  • Crypto
Washingtoner

Juventix Regenerative Medical PRP Highlighted in University-Published Research Study
Washingtoner/10277008

Trending...
  • Wohler announces three SRT monitoring enhancements for its iVAM2-MPEG monitor and the addition of front panel PID selection of A/V/subtitle streams
  • Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm
  • Curated Domain Name Marketplace
Laboratory Testing for Product Validation BSR Labs Juventix PRP Study Table Juventix Packaging With Tubes Juventix Regenerative Medical, LLC
TAMPA, Fla. - Washingtoner -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.

The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.

Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
  • 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
  • 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
  • Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
  • Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
  • Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.
"The inclusion of Juventix PRP in a peer-reviewed study underscores our commitment to delivering scientifically validated, high-quality regenerative solutions," said Lance Liberti, CEO of Juventix Regenerative Medical. "Our focus on innovation ensures practitioners can trust Juventix PRP for consistent, superior patient outcomes."

More on Washingtoner
  • Liftoff Enterprises Launches Liftoff Spotlight,™ A Nationally Broadcast Platform Turning Conversations Into Revenue
  • From November 24th to 27th, Fuqing Invites You to Join Us at BIG 5 to Jointly Build a New Future for Middle Eastern Architecture
  • Dispelling Holiday Suicide Myth: CDC Data Shows Suicide Rates Lowest in December; International Survivors of Suicide Day Emphasizes Need for Action
  • Stratum Nutrition's OVOLUX™ Named 2025 "Collagen Ingredient of the Year" by Beauty Innovation Awards
  • Sons of Liberty Museum Unveils "America at 250" Mobile Exhibit on Veterans Day 2025

Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/

About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.

For more information, visit www.Juventix.com or contact:
📞 (866) 693-4777

More on Washingtoner
  • Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • North 5th Street – Between North Tacoma Avenue and North Division Avenue – to Close in Phases for Maintenance Starting December 1
  • Bent Danholm Releases New Video Breaking Down the Rising Debate Over 50-Year Mortgages
  • New Smile Now Introduces RAYFace 3D Scanner to Advance Digital Surgery
  • Ali Alijanian, DDS Featured in The Profitable Dentist Magazine

✉️ Email:
hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.

Media Contact
Lance Liberti
***@juventix.com
866-693-4777


Source: Juventix Regenerative Medical, LLC

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
  • Spokane: Firework Thrown From a Vehicle Causes Severe Injuries to Another
  • Spokane: Coffee With Council District 2 Council Members
  • 2026 Oscars Betting Odds: One Battle After Another Favored for Best Picture
  • Allen Field Co., Inc. Components Selected for Esko ArtiosCAD 3D Component Library
  • Monroe Welcomes The Great Junk Hunt – This Vintage Market is Getting Ready for the Holidays!
  • Thirteen Reasons Why Gyminny Kids Is San Diego's Best Gymnastics Gym
  • Kennedy Funding Closes Challenging $3 Million Cash-Out Refinance Loan in Rural Washington State
  • Heritage At Manalapan - A New Luxury Single Family Home Community Coming Late 2025
  • The Lashe® Announces Exclusive November Savings for Lash and Beauty Professionals
  • Corcoran DeRonja Real Estate Welcomes Siobhán Simões to Its Growing Team
  • November is Lung Cancer Awareness Month: Screening Saves Aims to Increase Access to Lung Screenings in NC
  • Valeo Health Leads a New Era of Longevity and Preventive Health in the UAE
  • Torch Entertainment Presents The Frozen Zoo
  • Spokane: Suspect Identified in Unsolved Murder of Margaret Anselmo
  • ATTENTION: Investors, Suppliers, Travelers, & All Stakeholders In American Aviation
  • Sweet Memories Vintage Tees Debuts Historic ORCA™ Beverage Nostalgic Soda Collection
  • UK Financial Ltd Celebrates Global Recognition as MayaCat (MCAT) Evolves Into SMCAT — The World's First Meme Coin Under ERC-3643 Compliance
  • U.S. Military to Benefit from Drone Tech Agreement with NovaSpark Energy, Plus Longer NASA Space Missions via Solar Power Leader: Ascent Solar $ASTI
  • $76 Million in Gold & Silver Holdings and Expanding Production — Pioneering the Future of Gold: Asia Broadband Inc. (Stock Symbol: AABB) is Surging
_catLbl0 _catLbl1

Popular on Washingtoner

  • New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks - 135
  • Applicants Sought for the Tacoma Community Redevelopment Authority Board
  • ExtraCarry Now Supports Taurus GX2 13-Round Mags and 15-Round Magazines
  • Oom Yung Doe Hosts Children's Halloween Safety Seminar in Kirkland
  • Award-Winning Author Zane Carson Carruth Featured in USA Today for Inspiring Mission to Nurture Young Hearts Through Storytelling
  • City of Tacoma’s Street Operations Crew Scheduled to Conduct Annual Snow and Ice Training on October 22 and 23
  • Frost Locker: New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy
  • Blogging Pioneer Sherry Bennett Celebrates 29 Years Online - From College Blogger to Successful Entrepreneur
  • City of Tacoma Files Pleadings with Washington State Court of Appeals Regarding Recent Superior Court Order on Initiative 2
  • Pepperdine University Malibu, California and Community Partners Recognized with 2025 ReadyCommunities Partnership National Service Award

Similar on Washingtoner

  • Dispelling Holiday Suicide Myth: CDC Data Shows Suicide Rates Lowest in December; International Survivors of Suicide Day Emphasizes Need for Action
  • Stratum Nutrition's OVOLUX™ Named 2025 "Collagen Ingredient of the Year" by Beauty Innovation Awards
  • Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • New Smile Now Introduces RAYFace 3D Scanner to Advance Digital Surgery
  • Ali Alijanian, DDS Featured in The Profitable Dentist Magazine
  • CCHR: Study Finds Involuntary Commitment Fails to Prevent Suicide, Raises Risk
  • ZEELOOL's Black Friday Sale Starts Early with Up to 80% Off Frames
  • Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
  • Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
  • The Lashe® Announces Exclusive November Savings for Lash and Beauty Professionals
Copyright © 2025 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute